Sort
39,280 grants matching “leukemia”
Molecular Mechanisms That Control the Quality of Synaptic Vesicle Recycling
$369,600Jihong Bai · Fred Hutchinson Cancer Research Center · R01 · FY2019 · GM
Translating Improved Pairing and Timing of Drug Combination Strategies
$369,600Brian J Druker · Oregon Health & Science University · U54 · FY2022 · CA
IDENTIFICATION OF TARGETS OF BCR ABL IN THE LEUKEMOGENIC
$369,579Brandeis University · R01 · FY2002 · CA
Trajectory and Architecture of Tumor Intrinsic Drug Resistance in AML
$369,544Jeffrey Wallace Tyner · Oregon Health & Science University · U54 · FY2022 · CA
Investigating novel synthetic lethal epigenetic interactions in Acute Myeloid Leukemia
$369,504Junwei Shi · University Of Pennsylvania · R01 · FY2023 · CA
Imaging and Regulation of Immune Function in HCT
$369,473Robert S Negrin · Stanford University · R01 · FY2018 · CA
Efficient, cost-effective, and ultrasensitive sequencing of somatic mutations and methylation
$369,468Stephen J Salipante · University Of Washington · R33 · FY2025 · CA
Targeting the GFI1-LSD1 Axis in T-Cell Acute Lymphoblastic Leukemia
$369,430Michael E Engel · University Of Virginia · R01 · FY2021 · CA
Chromosome Architecture and Domains of Repression
$369,420Univ Of Med/Dent Nj-R W Johnson Med Sch · R01 · FY2004 · GM
Endocrine-immune-reproductive System Interactions
$369,407George P Chrousos · Child Health And Human Development · Z01 · FY2007 · HD
BIOMARKERS OF TREATMENT RELATED LEUKEMIA
$369,395Children'S Hospital Of Philadelphia · R01 · FY2001 · CA
BIOMARKERS OF TREATMENT RELATED LEUKEMIA
$369,395Children'S Hospital Of Philadelphia · R01 · FY2002 · CA
BIOMARKERS OF TREATMENT RELATED LEUKEMIA
$369,395Childrens Hospital Of Philadelphia · R01 · FY2004 · CA
BIOMARKERS OF TREATMENT RELATED LEUKEMIA
$369,395Children'S Hospital Of Philadelphia · R01 · FY2003 · CA
Eradication of Escaped Variant Tumor Cells for Cancer Immunotherapy
$369,383Yong Lu · Methodist Hospital Research Institute · R01 · FY2024 · CA
Eicosanoids and Vascular Wall Remodeling
$369,375Gadiparthi N Rao · University Of Tennessee Health Sci Ctr · R01 · FY2015 · HL
Lysine Acetyltransferases in Myelopoiesis and Leukemia
$369,370Daniel G Tenen · Brigham And Women'S Hospital · P01 · FY2018 · CA
Tsc1/mTOR axis in immune homeostasis and tumorigenesis
$369,350Hongbo Chi · St. Jude Children'S Research Hospital · R01 · FY2014 · CA
Lysine Acetyltransferases in Myelopoiesis and Leukemia
$369,350Daniel G Tenen · Brigham And Women'S Hospital · P01 · FY2017 · CA
Discovery and Development of a Selective pan-FLT3-ITD Kinase Inhibitor Clinical Candidate for the Treatment of FLT3-ITD-Driven AML
$369,332Hong-Yu Li · University Of Arizona · R01 · FY2015 · CA
Lysine Acetyltransferases in Myelopoiesis and Leukemia
$369,329Daniel G Tenen · Brigham And Women'S Hospital · P01 · FY2016 · CA
Role of p21 activated kinase in Leukemogenesis
$369,310Reuben Kapur · Indiana University Indianapolis · R01 · FY2021 · CA
Role of p21 activated kinase in Leukemogenesis
$369,310Reuben Kapur · Indiana University Indianapolis · R01 · FY2025 · CA
Lysine Acetyltransferases in Myelopoiesis and Leukemia
$369,287Daniel G Tenen · Brigham And Women'S Hospital · P01 · FY2015 · CA
Glial Cell Inflammatory Mechanisms & CNS Regulation
$369,209Janice Ellen Clements · Johns Hopkins University · R01 · FY2006 · NS